News and Events
January 25, 2023 Press
Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, has announced it has entered into an agreement to acquire the IndivuServ business unit of Indivumed GmbH. A Sales and Purchase Agreement (SPA) between both parties was executed on December 29, 2022, and subject to customary closing adjustments the transaction is expected to close in April 2023.
Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank Read moreDecember 23, 2022 News
Ending the year - Today. Tomorrow. Together.
A review on 2022 and Indivumed's 20 year long history, and outlook, and thank you
Ending the year - Today. Tomorrow. Together. Read moreSeptember 07, 2022 Press
Indivumed and CELLphenomics Announce Partnership
Indivumed GmbH and CELLphenomics GmbH today announced a partnership to create a unique platform for faster and more efficient discovery and validation of therapeutic targets. The new platform combines Indivumed’s AI-driven oncology analytics with CELLphenomics’ expertise in creating organoid models to identify therapeutically relevant targets and validate these targets in-vitro. The partnership will accelerate cancer drug development by linking in-silico target discovery and development with matched patient-derived tumor models for downstream validation.
Indivumed and CELLphenomics Announce Partnership Read moreApril 28, 2022 News
Indivumed Expands Its Certified Provider Portfolio
Today, we are happy to announce that Indivumed is now a “Certified Service Provider” of the Spatial Transcriptomics technology (Visium Spatial Gene Expression) by 10x Genomics not only for fresh frozen- but for FFPE tissue as well.
Indivumed Expands Its Certified Provider Portfolio Read more
Research Publications
Product Information
Biospecimen Products
To meet all your needs in cancer research and drug development we offer you a broad spectrum of high-quality biospecimen samples including clinical data.
Applications and CRO Services
To further support your efforts in personalized oncology we offer you an holistic range of clinical, laboratory, and research services.
ISO-Certified Expertise
Indivumed’s long-standing expertise is ISO 9001:2015-certified and includes the collection, processing and storage of biological samples and clinical data from cancer patients; laboratory services and AI-advanced data analytics of multi-omics cancer data for biopharma service offerings as well as IP-generation and product development in the field of personalized oncology.
Download the ISO-Certificate
Video
Discover more about Indivumed’s work and the future of personalized cancer medicine in the following lectures and videos.
IndivuType
The global multi-omics cancer solution
In Focus:
Precision Oncology – Interview with Prof. Dr. Hartmut Juhl, Indivumed Group
In Focus:
Partnerships – Interview with Prof. Dr. Hartmut Juhl, Indivumed Group
In Focus:
nRavel – Interview with Dr. Jonathan Woodsmith, Indivumed Group
In Focus:
Data Depth – Interview with Dr. Jonathan Woodsmith, Indivumed Group
In Focus:
Data Quality – Interview with Dr. Jonathan Woodsmith, Indivumed Group
In Focus:
Our Vision – Interview with Dr. Jonathan Woodsmith, Indivumed Group
In Focus:
ASCO 2021 – Interview with Roald Forsberg, PhD, Indivumed Group
In Focus:
Our Mission – Interview with Roald Forsberg, PhD, Indivumed Group
In Focus:
IndivuType – Interview with Roald Forsberg, PhD, Indivumed Group
In Focus:
AI – Interview with John L. Marshall, MD, Georgetown University Hospital
In Focus:
ASCO 2021 – Interview with John L. Marshall, MD, Georgetown University Hospital
In Focus:
Precision Oncology – Interview with John L. Marshall, MD, Georgetown University Hospital
Partners
Global Clinical Network
Global Clinical Network
Interview Prof. Jesus Garcia Foncillas – Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain
Global Clinical Network
Interview Dr. Rafael López López – Hospital Clínico Universitario de Santiago, Barcelona, Spain
Global Clinical Network
Interview Dr. Xavier Matias-Guiu – Hospital Universitario Arnau de Vilanova Lleida, Lleida, Spain
Global Clinical Network
Interview Prof. Gerry Melino – Hospital Tor Vergata Italy, Rome, Italy
Global Clinical Network
Interview Prof. Sun Young Rha – Severance Hospital Yonsei University Health System, Seoul, South Korea
Global Clinical Network
Interview Dr. Carlos Sampaio – Clinica AMO Brazil, Salvador, Brazil
Global Clinical Network
Interview Prof. Takayuki Yoshino – National Cancer Center Hospital East Japan, Chiba, Japan
Cooperational Partnerships
Cooperational Partnership
Interview with Roald Forsberg, PhD about Gnosis Partnership – Gnosis Data Analysis
Cooperational Partnership
Interview with Oliver Rinner, PhD about Biognosys Partnership – Biognosys AG
Scientific Lectures
Scientific Lectures
22CEMIT Symposium: Overview and Perspectives for Translating Multi-omics into Clinical Utility in Solid Tumors
Speaker: Prof. Dr. Hartmut Juhl
Scientific Lectures
Next In Personalized Medicine - Cancer-Phenotyping
Speaker: Hartmut K. Land, Ph.D., Prof. Dr. Hartmut Juhl
Scientific Lectures
Personalized Oncology – Why Tissue Is the Issue When Characterizing Tumor Expression
Speaker: Dr. Bernd Gromoll, Prof. Dr. Hartmut Juhl
Scientific Lectures
Opening Remarks and The Importance of Biobanking on Personalized Medicine
Speaker: Carolyn Compton, M.D., PhD
Scientific Lectures
The Challlenge and Importance of Standardizing Pre-Analytical Variables in Surgical Pathology Specimens for Clinical Care and Translational Research
Speaker: David Hicks, M.D.
Scientific Lectures
How to Assess Tissue Quality to Improve Tissue Diagnostics
Speaker: Jim Crawford, M.D., PhD
Scientific Lectures
The Future of Personalized Medicine in Oncology Has Begun
Speaker: John Marshall, M.D., PhD
Scientific Lectures
IndivuType: Indivumed's Global Cancer Database Solution for Drug Development and Patient Care
Speaker: Prof. Dr. Hartmut Juhl